Clonality assessment of patients with PMBL in the 5′RACE cohort (n = 75)
| IgVH + IgVL clonality assessment (5ʹRACE set, n = 75) . | n (%) . |
|---|---|
| Confirmed B-cell clonality | 63 (84) |
| IgM kappa | 3 (4) |
| IgM lambda | 1 (1.3) |
| IgM polyclonal | 1 (1.3) |
| IgD kappa | 1 (1.3) |
| IgG kappa | 24 (32) |
| IgG lambda | 15 (20) |
| IgG polyclonal | 1 (1.3) |
| IgE kappa | 2 (2.7) |
| IgE polyclonal | 1 (1.3) |
| IgA kappa | 4 (5.3) |
| IgA lambda | 6 (8) |
| IgA polyclonal | 1 (1.3) |
| Polyclonal heavy chain and clonal kappa light chain | 1 (1.3) |
| Polyclonal heavy chain and clonal lambda light chain | 2 (2.7) |
| B-cell clonality not detectable | 12 (16) |
| Polyclonal profile | 12 (16) |
| IgVH + IgVL clonality assessment (5ʹRACE set, n = 75) . | n (%) . |
|---|---|
| Confirmed B-cell clonality | 63 (84) |
| IgM kappa | 3 (4) |
| IgM lambda | 1 (1.3) |
| IgM polyclonal | 1 (1.3) |
| IgD kappa | 1 (1.3) |
| IgG kappa | 24 (32) |
| IgG lambda | 15 (20) |
| IgG polyclonal | 1 (1.3) |
| IgE kappa | 2 (2.7) |
| IgE polyclonal | 1 (1.3) |
| IgA kappa | 4 (5.3) |
| IgA lambda | 6 (8) |
| IgA polyclonal | 1 (1.3) |
| Polyclonal heavy chain and clonal kappa light chain | 1 (1.3) |
| Polyclonal heavy chain and clonal lambda light chain | 2 (2.7) |
| B-cell clonality not detectable | 12 (16) |
| Polyclonal profile | 12 (16) |